Hikma Pharmaceutical reported 82.96B in Current Liabilities for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Artemis Alpha ATS:LN 537.4M 2.5M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Bayer BAYN:GR € 33643M 2624M
Fresenius FRE:GR € 14300M 162M
Galapagos GLPG:NA € 550.72M 12.17M
Genmab GEN:DC DK 1944M 605M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Hikma Pharmaceutical HIK:LN 82.96B 7.86B
Lonza Group LONN:SW 2.63B 256M
Merck MRK:GR € 9718M 489M
Orion ORNBV:FH € 235.9M 199.9M
Recordati REC:IM € 851.2M 126.18M